ElectroPhysiology Frontiers S.p.A.

ElectroPhysiology Frontiers is a Milan, Italy-based MedTech company dedicated to revolutionizing the treatment of Atrial Fibrillation (AFib). We’ve developed a groundbreaking, easy-to-use ‘single-shot’ catheter ablation system designed to deliver more durable and long-lasting ablations, significantly reducing the risk of AFib recurrence after pulmonary vein isolation (PVI).

Our innovative catheter design, utilizing both pulsed-field ablation (PFA) and radiofrequency (RFA) technologies, streamlines the ablation process, making it safer and more efficient for clinicians.

Built upon decades of expertise in cardiac electrophysiology, EPF’s leadership team – comprised of internationally recognized professionals – is committed to advancing patient care through cutting-edge technology. We are focused on improving outcomes and positively impacting patients, healthcare professionals, and healthcare systems globally.

ElectroPhysiology Frontiers is a privately held company with a growing presence in both Italy and the United States, currently operating with a team of 2-10 dedicated professionals.